HiFiBiO SAS has achieved a milestone in its antibody research collaboration with Pfizer, triggering an undisclosed milestone payment to HiFiBiO.   The collaboration, signed in 2014, is for the development and validation of HiFiBiO’s high throughput antibody discovery platform for mining of immune repertoires. The platform uses single cell-based screening of entire antibody-secreting B cell populations along with bar coded next-gen sequencing and rapid DNA synthesis to identify multiple leads a...